Literature DB >> 35837201

Association of social determinants of health with late diagnosis and survival of patients with pancreatic cancer.

Jesus C Fabregas1,2, Kristen E Riley3, Jeannine M Brant4, Thomas J George1,2, E John Orav3,5, Miranda B Lam6,7.   

Abstract

Background: Pancreatic cancer disparities have been described. However, it is unknown if they contribute to a late diagnosis and survival of patients with metastatic disease. Identifying their role is important as it will open the door for interventions. We hypothesize that social determinants of health (SDH) such as income, education, race, and insurance status impact (I) stage of diagnosis of PC (Stage IV vs. other stages), and (II) overall survival (OS) in Stage IV patients.
Methods: Using the National Cancer Database, we evaluated a primary outcome of diagnosis of Stage IV PC and a secondary outcome of OS. Primary predictors included race, income, education, and insurance. Covariates included age, sex and Charlson-Deyo comorbidity score. Univariate, multivariable logistic regression models evaluated risk of a late diagnosis. Univariate, multivariable Cox proportional hazards model examined OS. 95% confidence intervals were used.
Results: 230,877 patients were included, median age of 68 years (SD 12.1). In univariate analysis, a better education, higher income, and insurance decreased the odds of Stage IV PC, while Black race increased it. In multivariable analysis, education [>93% high-school completion (HSC) vs. <82.4%, OR 0.96 (0.93-0.99)] and insurance [private vs. no, OR 0.72 (0.67-0.74)] significantly decreased the risk of a late diagnosis, whereas Black race increased the odds [vs. White, OR 1.09 (1.07-1.12)]. In univariate Cox analysis, having a higher income, insurance and better education improved OS, while Black race worsened it. In multivariable Cox, higher income [>$63,333 (vs. <$40,277), HR 0.87 (0.85-0.89)] and insurance [private vs. no, HR 0.77 (0.74-0.79)] improved OS. Conclusions: SDH impacted the continuum of care for patients with advanced pancreatic cancer, including stage at diagnosis and overall survival. 2022 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  Survival; disparities; pancreatic cancer; social determinants of health (SDH)

Year:  2022        PMID: 35837201      PMCID: PMC9274045          DOI: 10.21037/jgo-21-788

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  29 in total

1.  Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic Adenocarcinoma.

Authors:  Nina N Sanford; Todd A Aguilera; Michael R Folkert; Chul Ahn; Brandon A Mahal; Herbert Zeh; Muhammad S Beg; John Mansour; David J Sher
Journal:  J Natl Compr Canc Netw       Date:  2019-11-01       Impact factor: 11.908

2.  Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States.

Authors:  Anna Tavakkoli; Amit G Singal; Akbar K Waljee; B Joseph Elmunzer; Sandi L Pruitt; Thomas McKey; Joel H Rubenstein; James M Scheiman; Caitlin C Murphy
Journal:  Clin Gastroenterol Hepatol       Date:  2019-06-13       Impact factor: 11.382

3.  Impact of Geography on Care Delivery and Survival for Noncurable Pancreatic Adenocarcinoma: A Population-Based Analysis.

Authors:  Elliott K Yee; Natalie G Coburn; Laura E Davis; Alyson L Mahar; Victoria Zuk; Vaibhav Gupta; Ying Liu; Craig C Earle; Julie Hallet
Journal:  J Natl Compr Canc Netw       Date:  2020-12-02       Impact factor: 11.908

4.  Disparities in utilization of treatment for clinical stage I-II pancreatic adenocarcinoma by area socioeconomic status and race/ethnicity.

Authors:  Douglas S Swords; Sean J Mulvihill; Benjamin S Brooke; David E Skarda; Matthew A Firpo; Courtney L Scaife
Journal:  Surgery       Date:  2018-12-11       Impact factor: 3.982

5.  Ethnic and racial disparities of pancreatic adenocarcinoma in Florida.

Authors:  Alexander M Fagenson; Sara M Grossi; Kelsey Musgrove; Naveenraj Solomon; Pura Rodriguez de la Vega; Gretel Castro; Henry A Pitt; Marcia Varella; Juan Zavallos; Juan Acuna
Journal:  HPB (Oxford)       Date:  2019-10-07       Impact factor: 3.647

6.  Cancer Statistics, 2021.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2021-01-12       Impact factor: 508.702

7.  The Impact of Residential Segregation on Pancreatic Cancer Diagnosis, Treatment, and Mortality.

Authors:  Barbara Aldana Blanco; Michael Poulson; Kelly M Kenzik; David B McAneny; Jennifer F Tseng; Teviah E Sachs
Journal:  Ann Surg Oncol       Date:  2020-11-01       Impact factor: 5.344

8.  Understanding Racial Disparities in Gastrointestinal Cancer Outcomes: Lack of Surgery Contributes to Lower Survival in African American Patients.

Authors:  John N Bliton; Michael Parides; Peter Muscarella; Katia T Papalezova; Haejin In
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-12-10       Impact factor: 4.254

9.  Racial Disparity in Pancreatoduodenectomy for Borderline Resectable Pancreatic Adenocarcinoma.

Authors:  George Molina; Thomas E Clancy; Thomas C Tsai; Miranda Lam; Jiping Wang
Journal:  Ann Surg Oncol       Date:  2020-07-10       Impact factor: 5.344

10.  Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.

Authors:  Mahdi Sheikh; Sahar Masoudi; Razieh Bakhshandeh; Alireza Moayyedkazemi; Farhad Zamani; Sepideh Nikfam; Masoumeh Mansouri; Neda Ghamarzad Shishavan; Saman Nikeghbalian; Paul Brennan; Reza Malekzadeh; Akram Pourshams
Journal:  PLoS One       Date:  2020-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.